[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356431-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356431-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","resveratrol-as-a-novel-yap-inhibitor-targeting-glioblastoma-progression-and-sensitizing-to-chemotherapy","Resveratrol as a Novel YAP Inhibitor Targeting - Glioblastoma Progression and Sensitizing to Chemotherapy","","Dysregulation of YAP, the terminal effector of the Hippo pathway, drives cancer progression and therapy resistance, yet its specific functions in glioblastoma (GBM) remain insufficiently defined. Single-cell RNA sequencing data from a published GBM dataset were reanalyzed for YAP expression across cell populations. YAP was silenced by shRNA in GBM cell lines and patient-derived GBM cells, and resveratrol was tested for growth inhibition. Results showed YAP and TEAD were strongly upregulated; YAP depletion suppressed malignant proliferation, spheroid formation, migration, and invasion. Resveratrol similarly inhibited YAP expression, restrained viability in 2D and 3D cultures, limited migration and invasion via EMT inhibition, and enhanced sensitivity to temozolomide and carmustine, supporting resveratrol as a potential adjunct YAP-targeted GBM therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/resveratrol-as-a-novel-yap-inhibitor-targeting-glioblastoma-progression-and-sensitizing-to-chemotherapy/356431/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/resveratrol-as-a-novel-yap-inhibitor-targeting-glioblastoma-progression-and-sensitizing-to-chemotherapy/356431.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main biological target studied in this article?","Question",{"text":63,"@type":64},"The study focuses on YAP, the terminal effector of the Hippo signaling pathway, and its cofactor TEAD, examining their role in glioblastoma progression and drug resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was YAP function tested in glioblastoma cells?",{"text":68,"@type":64},"YAP was silenced using shRNA in glioblastoma cell lines and patient-derived GBM cells, and multiple functional assays were used to assess proliferation, spheroid formation, migration, invasion, and drug sensitivity.",{"name":70,"@type":61,"acceptedAnswer":71},"What effects did resveratrol have on GBM and chemotherapy response?",{"text":72,"@type":64},"Resveratrol inhibited YAP expression, reduced proliferation and viability in both monolayer and 3D spheroid cultures, impaired migration and invasion through EMT inhibition, and increased sensitivity to temozolomide and carmustine, raising their cytotoxic effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356431,1790470912,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Cancer Science  \nORIGINAL ARTICLE  OPEN ACCESS   \nResveratrol as a Novel YAP Inhibitor Targeting  \nGlioblastoma Progression and Sensitizing to Chemotherapy  \nWannawat Khotchawan1,2 | Chanchao Lorthongpanich2  | Pakpoom Kheolamai3,4 | Sith Sathornsumetee5 | Surapol Issaragrisil2,6  \n1Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand | 2Siriraj Center of Excellence for Stem Cell Research (SiSCR), faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand | 3Division of Cell Biology, Faculty of Medicine, Thammasat University, Khlong Luang, Thailand | 4Center of Excellence in Stem Cell Research and Innovation, Faculty of Medicine, Thammasat University, Khlong Luang, Thailand | 5Siriraj Center of Research Excellence Management, Siriraj Hospital, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok,  \nThailand | 6Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Correspondence: Chanchao Lorthongpanich ([chanchao.lor@mahidol.ac.th](chanchao.lor@mahidol.ac.th)) | Surapol Issaragrisil ([surapol.iss@mahidol.ac.th](surapol.iss@mahidol.ac.th))  \nReceived: 4 September 2025 | Revised: 8 December 2025 | Accepted: 2 January 2026  \nKeywords: adjuvant therapy | glioblastoma | hippo signaling pathway | resveratrol | yes-associated protein  \nABSTRACT  \nDysregulation of YAP, the terminal effector of the Hippo pathway, contributes to cancer progression and drug resistance. Its role in glioblastoma (GBM), the most aggressive brain cancer, remains incompletely understood. Single-cell RNA sequencing data from a published GBM dataset were reanalyzed to assess YAP expression across cell populations. YAP was silenced via shRNA in GBM cell lines (U-251 MG, U-87 MG) and patient-derived GBM cells. Resveratrol (RV), a natural blood–brain barrier–permeable compound, was evaluated for growth inhibition and YAP-targeted effects. Functional assays measured proliferation, spheroid formation, migration, invasion, and drug sensitivity. YAP and its cofactor TEAD were highly upregulated in GBM cells compared with normal brain and stromal cells. YAP depletion by shRNA suppressed proliferation, spheroid formation, migration, and invasion. RV treatment similarly inhibited YAP expression, reducing proliferation and viability in monolayer and 3D spheroid cultures, and impairing migration and invasion via epithelial–mesenchymal transition (EMT) inhibition. RV-mediated YAP suppression also enhanced sensitivity to temozolomide (TMZ) and carmustine (BCNU), increasing their cytotoxicity in GBM cells. RV acts as a novel YAP inhibitor in GBM, impairing malignant phenotypes and potentiating the effects of standard chemotherapy. These findings support RV as a potential adjunct in YAP-targeted GBM therapy, warranting further in vivo validation for clinical translation.  \n1 | Introduction  \nGlioblastoma (GBM), a very aggressive grade IV glioma, is the most common and lethal adult brain cancer without effective treatment [1, 2] . The difficult-to-access tumor location and the blood–brain barrier (BBB) further complicate treatment by hindering tumor resection and limiting drug delivery [3] . Furthermore, temozolomide (TMZ), the standard chemotherapy  \nfor GBM, often develops resistance in many patients. This resistance is caused by genetic and epigenetic alterations in tumor cells and the tumor microenvironment [4–7] . These challenges highlight the urgent need for new or adjuvant GBM therapies to improve treatment outcomes.  \nDysregulation of cell signaling pathways, particularly Hippo signaling, leads to overexpression of the Yes-associated protein  \n\n| Abbreviations: BBB, Blood–brain barrier; BCNU, Carmustine; EMT, Epithelial–mesenchymal transition; GBM, Glioblastoma; RV, Resveratrol; TEAD, TEA domain family member; TMZ, Temozolomide; VP, Verteporfin; YAP, Yes-Associated Protein. |\n| --- |\n| This is an open access article under ","cbCaihBtl8PmzK4D","https://ap.wps.com/l/cbCaihBtl8PmzK4D","pdf",4095440,16,"English","# Introduction\n## Background: Glioblastoma challenges and chemotherapy resistance\n## YAP/Hippo pathway as a therapeutic target\n## Rationale for resveratrol as a BBB-permeable YAP inhibitor","[{\"question\":\"What is the main biological target studied in this article?\",\"answer\":\"The study focuses on YAP, the terminal effector of the Hippo signaling pathway, and its cofactor TEAD, examining their role in glioblastoma progression and drug resistance.\"},{\"question\":\"How was YAP function tested in glioblastoma cells?\",\"answer\":\"YAP was silenced using shRNA in glioblastoma cell lines and patient-derived GBM cells, and multiple functional assays were used to assess proliferation, spheroid formation, migration, invasion, and drug sensitivity.\"},{\"question\":\"What effects did resveratrol have on GBM and chemotherapy response?\",\"answer\":\"Resveratrol inhibited YAP expression, reduced proliferation and viability in both monolayer and 3D spheroid cultures, impaired migration and invasion through EMT inhibition, and increased sensitivity to temozolomide and carmustine, raising their cytotoxic effects.\"}]","Resveratrol as a Novel YAP Inhibitor Targeting - Glioblastoma Progression and Sensitizing to Chemotherapy | PDF",1790125314,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99f0d8e6681934240c594697a13ccaf3.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ebb1da6338ddb3ce6f4589a3a49024a.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6e8c22c4bee855a352a96e2a481f798.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14c54005a65bcdc319f43ce0107559af.webp",980,1287]